FIELD: medicine, oncology. SUBSTANCE: at the first stage of treatment an antitumor preparation and hyaluronic acid preparation (molecular mass is less 750 000 Da) are injected to patient in tumor directly. At the second stage the preparation of the same acid in combination with the preparation taken among the group of nonsteroidal anti-inflammatory preparations, chemotherapeutic agent, in part, antioxidant are administrated to patient by systemic schedule. Stages of treatment are repeated up to achievement of clinical effect. EFFECT: decreased activity of tumor process development. 6 cl, 3 tbl, 446 dwg
